Q32 Bio FIXX Cash Flow Statement (2017-2026)

NASDAQ FIXX
$11.68 +0.41 (+3.64%)
At close: Sep 1, 2026 · 4:00 PM EDT
Reported Financials

Q32 Bio Quarterly Cash Flow Statement

Periods 38 quarters
Latest Jun 2026

Q32 Bio reported cash from operations of -$3.08M and free cash flow of -$3.31M for the quarter ended Jun 2026, up 71.1% year over year. This cash flow statement covers 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-30.61M-13.47M92.66M-27.94M-31.64M-30.86M-6.84M-5.81M-13.90M-27.20M1.21M-15.53M-17.59M-14.19M-11.03M-9.49M-7.39M57.73M-7.72M-9.12M
Share-based CompensationStock Comp.
7.53M4.66M10.01M9.98M9.62M3.09M12.60M12.75M12.43M0.52M2.03M2.15M2.00M1.25M1.94M1.27M8.40M1.47M2.26M2.25M
Cash from OperationsCash from Ops.
-25.39M-30.43M-30.68M-30.85M-24.93M-27.20M-12.50M-11.37M15.90M-10.71M-14.55M-22.21M-19.52M-11.43M-12.48M-10.65M-4.23M-6.18M-6.34M-3.08M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
-0.25M1.56M-0.04M0.13M0.78M1.07M0.13M0.14M0.14M0.14M0.14M0.14M0.15M0.15M0.15M0.15M0.16M0.16M0.16M0.17M
Amortization of Deferred ChargesAmort. Deferred Charges
0.03M0.03M0.01M0.03M0.03M0.07M0.05M0.05M0.05M0.05M0.05M0.04M0.03M-0.07M
Change in Working Capital
Change in Account PayablesChange Payables
-2.11M-1.36M7.70M-6.06M1.07M-3.69M-0.82M0.09M1.13M1.64M0.93M-2.48M-1.23M1.73M-0.28M-1.80M0.06M-0.09M-0.23M0.91M
Change in Accured ExpensesChange Accured Exp.
2.33M1.27M-4.99M6.63M4.03M1.75M-2.85M-1.20M1.89M2.35M-2.22M-2.69M-1.78M-1.02M-2.23M-0.89M-0.51M0.31M-0.48M0.04M
Change in TaxesChange Taxes
0.97M-0.10M
Other Working Capital ChangesOther WC Changes
-1.60M-0.80M-0.80M-0.80M-0.80M-0.80M-0.80M-0.35M
Investing Activities
Capital ExpendituresCapex
0.48M0.34M1.15M0.12M0.01M0.01M0.12M0.08M0.37M3.93M0.60M-0.00M0.01M0.25M0.33M0.18M0.24M0.21M0.17M0.23M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.22M
Divestments
130.00M
Change in Acquisitions & DivestmentsChange Acquisitions
44.00M39.46M8.00M18.00M0.10M9.90M10.00M
Cash from Investing ActivitiesCash from Investing
4.52M43.66M168.31M-41.37M-108.22M17.99M-0.01M0.00M-0.00M0.10M9.89M9.94M-0.00M7.00M
Financing Activities
Other financing activitiesOther financing
0.38M0.00M0.44M0.12M0.03M0.01M0.01M0.08M0.38M1.00M0.32M
Cash from Financing ActivitiesCash from Financing
0.38M0.00M0.44M0.12M0.03M0.01M0.01M0.30M0.08M99.35M-5.52M1.00M0.32M-1.56M-1.56M8.80M58.59M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
2.20M2.58M3.09M2.84M3.48M0.90M1.07M0.07M0.51M0.09M
Net Equity Issued and RepurchasedNet Equity Issued
42.00M10.36M
Additional items
Change in Cash
-20.48M13.23M138.07M-72.22M-133.03M-9.18M-12.49M-11.35M16.20M-10.64M84.89M-17.85M-8.58M-11.11M-12.48M-10.65M-5.79M-0.74M2.45M55.52M
Free Cash FlowFCF
-25.86M-30.77M-31.83M-30.97M-24.94M-27.21M-12.62M-11.44M15.53M-14.65M-15.15M-22.21M-19.53M-11.68M-12.81M-10.83M-4.47M-6.39M-6.52M-3.31M
Net Cash FlowNCF
-20.48M13.23M138.07M-72.22M-133.03M-9.18M-12.49M-11.35M16.20M-10.64M84.89M-17.85M-8.58M-11.11M-12.48M-10.65M-5.79M-0.74M2.45M55.52M